Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of 1% and 3% Topical MIinocycline Gel (HY01) in Patients With Papulopustular Rosacea
Conditions
Interventions
1% Topical Minocycline Gel
3% Topical Minocycline Gel
+1 more
Locations
23
United States
Clinical Site - 15
Bryant, Arkansas, United States
Clinical Site - 20
Rogers, Arkansas, United States
Center for Dermatology Clinical Research, Inc.
Fremont, California, United States
Clinical Site - 19
Santa Monica, California, United States
Clinical Site - 5
Tampa, Florida, United States
Clinical Site - 16
Boise, Idaho, United States
Start Date
October 30, 2017
Primary Completion Date
March 1, 2019
Completion Date
July 1, 2019
Last Updated
November 8, 2019
NCT07106957
NCT06466018
NCT04108897
NCT07250165
NCT04214483
NCT06969300
Lead Sponsor
Hovione Scientia Limited
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions